INTRABODY CONTROL OF EXPANDED-REPEAT NEURODEGENERATION

$250,000R42FY2000NSNIH

Intraimmune Therapies, Inc., Boston MA

Investigators

Linked publications & trials

Paper 15837560 Paper 14969746 Paper 12718899 Paper 11296304 Paper 11162318

View original record on NIH RePORTER →